Edition:
United States

Hutchison China MediTech Ltd (HCM.OQ)

HCM.OQ on NASDAQ Stock Exchange Global Select Market

28.40USD
17 Sep 2018
Change (% chg)

$0.15 (+0.53%)
Prev Close
$28.25
Open
$28.18
Day's High
$28.49
Day's Low
$28.00
Volume
38,015
Avg. Vol
27,401
52-wk High
$42.00
52-wk Low
$25.10

Latest Key Developments (Source: Significant Developments)

Hutchison China Meditech says ‍underwriters elected to purchase an additional 1.5 mln ADSs
Friday, 27 Oct 2017 07:10am EDT 

Oct 27 (Reuters) - Hutchison China Meditech Ltd :UNDERWRITERS HAVE ELECTED TO PURCHASE AN ADDITIONAL 1.5 MILLION ADSS AT OFFERING PRICE OF US$26.50 PER ADS.‍TOTAL GROSS PROCEEDS OF OFFERING IS APPROXIMATELY US$301.3 MILLION​.  Full Article

Chi-Med reports preliminary phase II data on fruquintinib combination
Monday, 16 Oct 2017 02:00am EDT 

Oct 16 (Reuters) - Hutchison China Meditech Ltd :CHI-MED REPORTS PRELIMINARY PHASE II DATA ON FRUQUINTINIB COMBINATION IN FIRST-LINE LUNG CANCER.HUTCHISON CHINA MEDITECH LTD SAYS ‍PRELIMINARY RESULTS IN 17 EFFICACY EVALUABLE PATIENTS SHOWED AN ORR OF 76 PERCENT AND A DCR OF 100 PERCENT​.HUTCHISON CHINA MEDITECH LTD SAYS ‍PRELIMINARY DATA FROM PHASE II TRIAL DEMONSTRATED PROMISING EFFICACY AND AN ACCEPTABLE SAFETY PROFILE​.  Full Article

Boost for 'made in China' medicine as Chi-Med wins key approval

LONDON Hutchison China MediTech has won Chinese approval for a closely watched new cancer drug in a significant boost for "made in China" medicine.

No consensus analysis data available.